Pro-inflammatory and anti-inflammatory cytokine increases after spinal instrumentation surgery

Journal of Spinal Disorders and Techniques

Volumn 15, Issue 4, 2002, Pages 294-300

  Takahashi, Jun ^a   Ebara, Sohei ^a   Kamimura, Mikio ^a   Kinoshita, Tetsuya ^a   Misawa, Hiromichi ^b   Shimogata, Mitsuhiko ^b   Tozuka, Minoru ^c   Takaoka, Kunio ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Orthopaedic Surgery   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cytokines; Prostheses and implants; Spinal surgery

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DECOMPRESSION SURGERY; FEMALE; HUMAN; INFLAMMATION; INSTRUMENTATION; LUMBAR SPINE; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPINE FUSION; SPINE SURGERY; MEDICAL INSTRUMENTATION; SPINAL CORD DECOMPRESSION;

EID: 0036704269     PISSN: 15360652     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024720-200208000-00006     Document Type: Article

References (38)

1. Jansen B, Peters G. Foreign body associated infection. J Antimicrob. Chemoth 1993;32:69-75.
2. Delmi M, Vaudaux P, Lew DP, et al. Role of fibronectin in staphylococcal adhesion to metallic surfaces used as models of orthopaedic devices. J Orthop Res 1994;12:432-8.
3. Abbey DM, Turner DM, Warson JS, et al. Treatment of postoperative wound infections following spinal fusion with instrumentation. J Spinal Disord 1995;4:278-83.
4. Ogawa M. Mechanisms of the development of organ failure following surgical insult: The 'second attack' theory. Clin Intensive Care 1996;7:34-8.
5. American College of Chest Physicians/Society of Critical Care Medicine. Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
6. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-8.
7. Sato T, Asanuma Y, Masaki Y, et al. Changes in tumor necrosis factor-α and inteleukin-1 beta production following liver surgery on cirrhotic patients. Hepatogastroenterology 1996;43:1148-53.
8. Sweed BY, Put P, Reen DG. Early induction of IL-6 in infants undergoing major abdominal surgery. J Pediatr Surg 1992;27:1033-7.
9. Biffl WL, Moore, Moore FA, et al. Interleukin 6 in the injured patient: Marker of injury or mediator of inflammation? Ann Surg 1996;224:647-64.
10. Le J, Vilcek J. Interieukin-6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989;61:588-602.
11. Hirano T, Yasukawa K, Harada H. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324:73-6.
12. Matsushima K, Morishita K, Yoshimura T, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988;167:1883-93.
13. Yoshimura T, Matsushima K, Tanaka S, at al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987;84:9233-7.
14. Kox WJ, Bone RC, Krausch D, et al. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. Arch Intern Med 1997;157:389-93.
15. Bone RC, Grodzin CJ, Balk RA, et al. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997;112:235-43.
16. de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin-10. Ann Med 1995;27:537-41.
17. Moore KW, O'Garra A, de Waal Malefyt R, et al. Interleukin-10. Annu Rev Immunol 1989;11:165-90.
18. Cassatella MA, Meda L, Gasperini S, et al. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994;179:1695-9.
19. Hart PH, Hunt EK, Boner CS, et al. Regulation of surface and soluble TNF receptors expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 1996;157:3672-80.
20. Joyce DA, Gibbons DS, Green P, et al. Two inhibitors of proinflammatory cytokines release of interleukin-10 and interleukin-4 have contrasting effects on the release of soluble P75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994;24:2699-705.
21. Granowitz EV, Santos AA, Poutsiaka DD, et al. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 1991;338:1423-4.
22. Schreuder H, Tardif C, Trump-Kallmeyer S, et al. A new cytokinereceptor binding mode revealed by the crystal structure of the IL-1 receptor with antagonist. Nature 1997;386:194-200.
23. Dembic Z, Loetscher H, Gubler U, et al. Two human TNF receptors have similar exlracellular, but distinct intracellular, domain sequences. Cytokine 1990;2:231-7.
24. Aderka D, Engelmann H, Maor Y, et al. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-9.
25. Stewart RJ, Marsden PA. Biologic control of the tumor necrosis factor and interleukin-1 signalling cascade. Am J Kidney Dis 1995;25:954-456.
26. Takahashi J, Ebara S, Kamimura M, et al. Early-phase enhanced inflammatory reaction after spinal instrumentation surgery. Spine 2001;26:1698-704.
27. Dinarello CA. Interleukin-1 and pathogenesis of the acute-phase response. N Engl J Med 1984;311:1413-8.
28. Darlington GJ, Wilson DR, Lachman LB. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 1986;103:787-93.
29. Perlmutter DH, Dinarello CA, Punsal PI, et al. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1985;78:1349-54.
30. Andus T, Geiger T, Hirano T, et al. Recombinant human B cell stimulatory factor 2 (BSF-2/IFNβ2) regulates β-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett 1987;221:18-22.
31. Gauldie J, Richards C, Harnish D, et al. Interferonβ2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987;84:7251-5.
32. Sakamoto K, Masuda T, Mita S, et al. Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines. Int J Clin Lab Res 1992;22:216-9.
33. Sakamoto K, Arakawa H, Mita S, et al. Elevation of circulating interleukin 6 after surgery: Factors influencing the serum level. Cytokine 1994;6:181-6.
34. Nivbrant B, Karlsson K, Kärrholm J. Cytokine levels in synovial fluid from hips with well-functioning or loose prostheses. J Bone Joint Surg Br 1999;81:163-6.
35. Thelander U, Larsson S. Quantitation of C-reactive protein levels and erythrocyte sedimentation rate after spinal surgery. Spine 1992;17:400-4.
36. Ganter U, Arcone R, Toniatti C, et al. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989;8:3773-9.
37. Mueller AR, Platz KP, Wiehe I, et al. Cytokine pattern in patients with infections after liver transplantation. Transpl Int 1996;9:126-31.
38. Gristina AG, Costerton JW. Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Orthop Clin North Am 1984;15:517-35.